These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2011144)

  • 1. Role of genetics and drug metabolism in human cancer risk.
    Nebert DW
    Mutat Res; 1991 Apr; 247(2):267-81. PubMed ID: 2011144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Populations and genetic polymorphisms.
    Weber WW
    Mol Diagn; 1999 Dec; 4(4):299-307. PubMed ID: 10671640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics.
    Wolf CR; Smith G
    Br Med Bull; 1999; 55(2):366-86. PubMed ID: 10723863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic control of drug metabolism.
    Nebert DW
    Adv Exp Med Biol; 1978; 97():55-83. PubMed ID: 347904
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.
    Kirchheiner J; Seeringer A
    Biochim Biophys Acta; 2007 Mar; 1770(3):489-94. PubMed ID: 17113714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of genetic polymorphisms of drug metabolism.
    Meyer UA; Zanger UM
    Annu Rev Pharmacol Toxicol; 1997; 37():269-96. PubMed ID: 9131254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interindividual differences in the reaction to drugs and poisons].
    Meyer UA
    Ther Umsch; 1992 Feb; 49(2):97-101. PubMed ID: 1553631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis.
    Elfaki I; Mir R; Almutairi FM; Duhier FMA
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2057-2070. PubMed ID: 30139042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics and human cancer.
    Nebert DW
    IARC Sci Publ; 1982; (39):365-80. PubMed ID: 7152614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues.
    Nebert DW; Ingelman-Sundberg M; Daly AK
    Drug Metab Rev; 1999 May; 31(2):467-87. PubMed ID: 10335448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Ah receptor and the dioxin-inducible [Ah] gene battery in toxicity, cancer, and signal transduction.
    Nebert DW; Puga A; Vasiliou V
    Ann N Y Acad Sci; 1993 Jun; 685():624-40. PubMed ID: 8395783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic drug metabolism.
    Relling MV
    Clin Pharm; 1989 Dec; 8(12):852-63. PubMed ID: 2689060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics. SNP-ing drugs to size.
    Gura T
    Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of cytochrome P450 genetic polymorphism--part I. Enzymatic system of cytochrome P450 and cytochrome P450 1A2].
    Duricová J; Grundmann M
    Ceska Slov Farm; 2011 Jun; 60(3):110-5. PubMed ID: 21838140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic susceptibility to toxic substances and its relationship to carcinogenesis.
    Hanke JZ
    IARC Sci Publ; 1984; (59):99-106. PubMed ID: 6336235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward individualized pharmaceutical care of East Asians: the value of genetic testing for polymorphisms in drug-metabolizing genes.
    Morrison A; Levy R
    Pharmacogenomics; 2004 Sep; 5(6):673-89. PubMed ID: 15335288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.